VIVA Foundation Announces Clinical Trial Results at The VEINS 2026

The VIVA Foundation, a not-for-profit organization focused on advancing vascular medicine through education and research, announced results from late-breaking clinical trials. The findings were presented at The VEINS 2026 conference, held in Las Vegas on October 4, 2026.

The conference convenes leading experts in vascular medicine. The presented results offer new insights into potential treatments and diagnostic methods. These studies are intended to improve patient care and understanding of vascular diseases.

The foundation emphasizes the importance of knowledge sharing for the field's development. The late-breaking results are crucial for developing new treatment protocols and strategies. The VIVA Foundation remains committed to advancing vascular medicine globally.

Discussions during the conference also covered future trends and challenges in the industry. The VIVA Foundation serves to provide a platform for sharing and discussing these important research outcomes.